Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphomaFrank Cichocki(University of Minnesota), Veronika Bachanová(University of Minnesota)Science Translational MedicineJuly 19, 202310.1126/scitranslmed.ade3341Cited by 44SaveCiteExport RISWatch citationsRelated PapersQuadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma|Nature Communications|2022|73